FDA Drug · D-0874-2026

FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19

Class II · Ongoing

Lack of Assurance of Sterility

Affected lots / codes — check yours against thisBatch# 6B093FI, Exp. 04/01/28; Batch# 6F511F1, Exp. 05/15/28

Recalling firm: Aurolab Trust, Madurai,
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 25,220 bottles
Distribution: VA
Recall initiated: September 17, 2026
Classified: September 28, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0874-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →